[The use of specific immunoglobulin for the treatment of children with acute herpetic encephalitis].
The use of specific immunoglobulin in combination with conventional agents of pathogenetic and symptomatic therapy was over two times more potent in reducing the lethality due to herpetic encephalitis. The residual phenomena in the survivors were also less pronounced in those given specific immunoglobulin. A relationship has been discovered between the outcomes of herpetic encephalitis and the time since the treatment with specific immunoglobulin was instituted, the rate of coma development and its intensity at the moment of the therapy onset.
Protas
I I
II
Kolomiets
A G
AG
Kolomiets
N D
ND
Grak
L A
LA
Shan'ko
L V
LV
D000208:Acute Disease; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004660:Encephalitis / Q000628:therapy*; D005260:Female; D006561:Herpes Simplex / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007223:Infant; D008297:Male
Ispol'zovanie spetsificheskogo immunoglobulina dlia lecheniia ostrogo gerpeticheskogo eńtsefalita u detei.